Kj Chang

KJ (Tiffany) Chang currently serves as the Chief Executive Officer of Acepix Biosciences, Inc., a position held since October 2018, following a tenure as Vice President of Product Management at the same company from July 2017 to August 2018. Prior experience includes a role as a Scientist at Fluidigm Corporation and as an IVD Development Scientist at Advanced Cell Diagnostics, where contributions included CE-IVD product development and optimization of detection sensitivity for circulating tumor cells in cancer patient blood. KJ Chang completed a Ph.D. in Biology with a focus on biochemistry and molecular biology at the California Institute of Technology, where KJ also held a postdoctoral scholar position in Biology from September 2005 to March 2013. An academic background includes a Master of Science degree in the Division of Life Science from National Central University.